<div id="readability-page-1"><div><p>WUXI APPTEC (02359.HK)<span> </span><span> 0.000 (0.000%)  </span> <span> Short selling $177.73M; Ratio 23.715%  </span>  announced a proposed issuance of RMB6.78 billion USD-settled zero-coupon convertible bonds due 2027. The initial conversion price is HKD153 per H share, representing a premium of approximately 17.6% over the closing price of HKD130.1 on the previous day (14th). The bonds may be fully converted into approximately 51.147 million H shares, equivalent to about 9.11% of the enlarged total issued H share capital and about 1.69% of the enlarged total issued share capital.</p><p>Based on the subscription, the estimated net proceeds are approximately USD1.023 billion. About 90% will be used for global capacity and capability expansion, while approximately 10% will be used for general corporate purposes. (jl/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)</p></div></div>

603259

159892

159849

<p>WUXI APPTEC plans to issue RMB6.78 billion in zero-coupon convertible bonds due 2027, with an initial conversion price of HKD153 per H share. This represents a 17.6% premium over the previous closing price. The bonds may convert into approximately 51.147 million H shares, accounting for about 9.11% of the enlarged H share capital. Estimated net proceeds are around USD1.023 billion, with 90% allocated for global expansion and 10% for general corporate purposes.</p>

AASTOCKS News

WuXi AppTec

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

China Merchants CSI Biotechnology Theme ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Guotai CSI Bio-medicine ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Hwabao WP CSI Pharmaceuticals ETF

First Trust NYSE Arca Biotech Index Fd

E Fund CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Minsheng Royal CSI Biotechnology Theme ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC SSE Health Care ETF Initiating Fund

ChinaAMC CSI Biotechnology Theme ETF

E Fund CSI 300 Health Care ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Bosera Hang Seng Health Care ETF(QDII)

WUXI APPTEC

WUXI APPTEC  Plans to Issue RMB6.78B Convertible Bonds